Simultaneous Runs of the Bayer VERSANT HIV-1 Version 3.0 and HCV bDNA Version 3.0 Quantitative Assays on the System 340 Platform Provide Reliable Quantitation and Improved Work Flow

Branched DNA (bDNA) assays to quantify human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) consist of three distinct steps, including sample processing, hybridization, and detection, and utilize the System 340 platform for plate incubation and washing. Sample processing differs:...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Elbeik, Tarek, Markowitz, Norman, Nassos, Patricia, Kumar, Uday, Beringer, Scott, Haller, Barbara, Ng, Valerie
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2004
Témata:
Virology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC446273/
https://ncbi.nlm.nih.gov/pubmed/15243070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.42.7.3120-3127.2004
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky